A detailed analysis of chromosome 6 in DNAs from prostate cancers was performed, to define a region for subsequent search for cancer genes. DNA from 4 prostate cancer cell lines and II xenografts was used for CGH and whole-chromosome allelotyping with polymorphic microsatellite markers. Loss of proximal 6q was studied in more detail by high-density allelotyping of xenografts, cell lines and 19 prostate tumour specimens from TURP. Seven of 15 xenografts and cell lines showed deletion of proximal 6q by CGH. Gain of 6q was found in 2 samples. Six samples showed 6p gain, and I had 6p loss. Allelotyping results were consistent with CGH data in II of 15 DNAs. In LNCaP and DUI45 cells, CGH showed 6p loss and 6q loss, respectively, but 2 allelic bands were detected for many polymorphic markers on these chromosome arms. These apparent discrepancies might be explained by aneuploidy. In cell line TSU, allelotyping demonstrated chromosome 6 deletion, which was not clearly detected by CGH, indicating loss of I copy of chromosome 6 followed by gain of the retained copy during progressive tumour growth. Loss of heterozygosity was detected in 9 of 19 TURP specimens. Combining all data, we found a common minimal region of loss at 6q14-16 with a length of 8.6 Mbp flanked by markers D6S 1609 and D6S417. One hundred and twenty-three STSs, ESTs, genes and candidate genes mapping in this interval were used to screen xenografts and cell lines for HDs, but none was detected. In summary, chromosome region 6q14-16 was deleted in approximately 50% of the prostate cancer specimens analysed. The high percentage of loss underscores the importance of genes within this region in prostate cancer growth.

Allelotyping, Chromosome 6, Comparative genomic hybridisation, Homozygous deletion, Prostate cancer
dx.doi.org/10.1002/ijc.10677, hdl.handle.net/1765/63973
International Journal of Cancer
Department of Pathology

Verhagen, P.C.M.S, Hermans, K.G.L, Brok, M, van Weerden, W.M, Tilanus, M.G.J, de Weger, R.A, … Trapman, J. (2002). Deletion of chromosomal region 6q14-16 in prostate cancer. International Journal of Cancer, 102(2), 142–147. doi:10.1002/ijc.10677